The results of open observational trial DIAMOND

Aim. DIAMOND (DIAMicrON in Daily practice) is an open non-randomized observational trial aimed to estimate the efficacy and safety of gliclazide(Diamicron MB) in routine clinical practice. Materials and methods. 394 patients with poor control of type 2 diabetes mellitus (T2 DM), previously treated...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Marina Vladimirovna Shestakova, Olga Konstantinovna Vikulova
Formato:	article
Lenguaje:	EN RU
Publicado:	Endocrinology Research Centre 2011
Materias:	type 2 diabetes mellitus hypoglycemia diamicron mb advance trial Nutritional diseases. Deficiency diseases RC620-627
Acceso en línea:	https://doaj.org/article/e7749dfe1c75471fb9d3a9e4c0656bbc
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:e7749dfe1c75471fb9d3a9e4c0656bbc
record_format	dspace
spelling	oai:doaj.org-article:e7749dfe1c75471fb9d3a9e4c0656bbc2021-11-14T09:00:16ZThe results of open observational trial DIAMOND2072-03512072-037810.14341/2072-0351-6232https://doaj.org/article/e7749dfe1c75471fb9d3a9e4c0656bbc2011-09-01T00:00:00Zhttps://www.dia-endojournals.ru/jour/article/view/6232https://doaj.org/toc/2072-0351https://doaj.org/toc/2072-0378Aim. DIAMOND (DIAMicrON in Daily practice) is an open non-randomized observational trial aimed to estimate the efficacy and safety of gliclazide(Diamicron MB) in routine clinical practice. Materials and methods. 394 patients with poor control of type 2 diabetes mellitus (T2 DM), previously treated with diet or one of oral antidiabeticdrug (OAD), were switched to Diamicron MB. Previous therapy was left unchanged, except for a sulfonylurea or glinide that were canceled. Results. After 6 months of Diamicron MB therapy (30% monotherapy, 70% combined therapy) target HbA1cMarina Vladimirovna ShestakovaOlga Konstantinovna VikulovaEndocrinology Research Centrearticletype 2 diabetes mellitushypoglycemiadiamicron mbadvance trialNutritional diseases. Deficiency diseasesRC620-627ENRUСахарный диабет, Vol 14, Iss 3, Pp 96-102 (2011)
institution	DOAJ
collection	DOAJ
language	EN RU
topic	type 2 diabetes mellitus hypoglycemia diamicron mb advance trial Nutritional diseases. Deficiency diseases RC620-627
spellingShingle	type 2 diabetes mellitus hypoglycemia diamicron mb advance trial Nutritional diseases. Deficiency diseases RC620-627 Marina Vladimirovna Shestakova Olga Konstantinovna Vikulova The results of open observational trial DIAMOND
description	Aim. DIAMOND (DIAMicrON in Daily practice) is an open non-randomized observational trial aimed to estimate the efficacy and safety of gliclazide(Diamicron MB) in routine clinical practice. Materials and methods. 394 patients with poor control of type 2 diabetes mellitus (T2 DM), previously treated with diet or one of oral antidiabeticdrug (OAD), were switched to Diamicron MB. Previous therapy was left unchanged, except for a sulfonylurea or glinide that were canceled. Results. After 6 months of Diamicron MB therapy (30% monotherapy, 70% combined therapy) target HbA1c
format	article
author	Marina Vladimirovna Shestakova Olga Konstantinovna Vikulova
author_facet	Marina Vladimirovna Shestakova Olga Konstantinovna Vikulova
author_sort	Marina Vladimirovna Shestakova
title	The results of open observational trial DIAMOND
title_short	The results of open observational trial DIAMOND
title_full	The results of open observational trial DIAMOND
title_fullStr	The results of open observational trial DIAMOND
title_full_unstemmed	The results of open observational trial DIAMOND
title_sort	results of open observational trial diamond
publisher	Endocrinology Research Centre
publishDate	2011
url	https://doaj.org/article/e7749dfe1c75471fb9d3a9e4c0656bbc
work_keys_str_mv	AT marinavladimirovnashestakova theresultsofopenobservationaltrialdiamond AT olgakonstantinovnavikulova theresultsofopenobservationaltrialdiamond AT marinavladimirovnashestakova resultsofopenobservationaltrialdiamond AT olgakonstantinovnavikulova resultsofopenobservationaltrialdiamond
_version_	1718429621841559552

The results of open observational trial DIAMOND

Ejemplares similares